• Blog
  • Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Report

    Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Report

    Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Report
    Report code - SR1448 Delivery - 2 Weeks
    Get Free Sample |
    Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Trends & Market Insig See more...

    Market Insights

    The global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of around x% during the forecast period.

    Figure: Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size, 2020-2026 (USD Billion)

    Molecular-HPV-Diagnostic-Equipment-Market-Forecast

    Wish to get a free sample? Register Here

    What is human papillomavirus infection?

    Human papillomavirus infection (HPV infection) is an infection caused by human papillomavirus (HPV), a DNA virus from the Papillomaviridae family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. The equipment used to diagnose molecular HPV infection includes services, assay kits, and a system.

    Key Players

    Key players operating in the Molecular Human Papillomavirus (HPV) Diagnostic Equipment market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Qiagen (Germany), Thermo Fisher Scientific (US), Abbott Laboratories (US), Hologic, Inc. (US), Cepheid (US), SEEGENE (South Korea), Takara Bio Inc. (Japan), Daan Gene (China), Promega Corporation (US), Greiner Bio-One International GmbH (Austria), Enzo Biochem, Inc. (US), Norgen Biotek Corp. (Canada), DiagCor Bioscience Incorporation Limited (HongKong), Guangdong Hybribio (China), ZytoVision GmbH (Germany), Arbor Vita Corporation (US) and Medical & Biological Laboratories Co., Ltd. (Japan).

    Market Dynamics

    The growth of the Molecular Human Papillomavirus (HPV) Diagnostic Equipment market is primarily driven by increasing incidences of cervical cancer. Cervical cancer is among the most common cancers among women above the age of 40. According to estimates from the WHO, cervical cancer is the fourth most frequent cancer, with approximately 570,000 cases and over 311,000 deaths in 2018. In addition to this, surging demand for advanced molecular HPV diagnostic equipment is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    Segments' Analysis

    Application Trends

    By application, the molecular human papillomavirus (HPV) diagnostic equipment market has been bifurcated into hospitals and clinics. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of required infrastructure and skilled healthcare professionals.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the high demand for advanced HPV diagnostic equipment coupled with the presence of key market players such as Agilent Technologies, Inc. (US) and Becton, Dickinson, and Company (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing prevalence of sexually transmitted diseases.

    COVID-19 Impact on Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market

    The outbreak of the COVID-19 virus posed significant challenges to the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product demand and supply for a short period.

    Critical Questions Answered in the Report

    • What are the key trends in the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market?
    • What are the key strategies adopted by the major vendors to lead in the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the molecular human papillomavirus diagnostic equipment market hopes to have the greatest opportunity to convert-

    • Molecular human papillomavirus (HPV) diagnostic equipment distributors
    • Molecular human papillomavirus (HPV) diagnostic equipment suppliers
    • Molecular human papillomavirus (HPV) diagnostic equipment manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Increasing incidences of cervical cancer is the prime factor driving the growth of molecular HPV diagnostic equipment market.

    The hospitals' segment is expected to register the significant growth in the molecular HPV diagnostic equipment market in the coming years.

    North America accounted for the largest share in the molecular HPV diagnostic equipment market in 2020.

    Molecular human papillomavirus (HPV) diagnostic equipment distributors, Molecular human papillomavirus (HPV) diagnostic equipment suppliers, Molecular human papillomavirus (HPV) diagnostic equipment manufacturers, Logistics organizations, Government bodies are the target audience in the molecular HPV diagnostic equipment market.

    •   
    ×